PT Merck Tbk (MERK.JK)
IDR 3580.0
(0.0%)
IDR 3580.0
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 18.13 Billion IDR | 12.05% |
| 2022 | 16.18 Billion IDR | -20.21% |
| 2021 | 20.28 Billion IDR | -7.89% |
| 2020 | 22.02 Billion IDR | 1674.58% |
| 2019 | 1.24 Billion IDR | -56.7% |
| 2018 | 2.86 Billion IDR | -12.65% |
| 2017 | 3.28 Billion IDR | 0.0% |
| 2016 | - IDR | 0.0% |
| 2015 | - IDR | 0.0% |
| 2014 | - IDR | 0.0% |
| 2013 | - IDR | 0.0% |
| 2012 | - IDR | 0.0% |
| 2011 | - IDR | 0.0% |
| 2010 | - IDR | 0.0% |
| 2009 | - IDR | 0.0% |
| 2008 | - IDR | 0.0% |
| 2007 | - IDR | 0.0% |
| 2006 | - IDR | 0.0% |
| 2005 | - IDR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 5.17 Billion IDR | -1.42% |
| 2024 Q1 | 20.5 Billion IDR | 13.06% |
| 2024 Q2 | 18.71 Billion IDR | -8.71% |
| 2023 Q3 | 16.05 Billion IDR | -4.42% |
| 2023 Q1 | 14.98 Billion IDR | -7.39% |
| 2023 FY | 18.13 Billion IDR | 12.05% |
| 2023 Q4 | 18.13 Billion IDR | 12.97% |
| 2023 Q2 | 16.79 Billion IDR | 12.04% |
| 2022 FY | 16.18 Billion IDR | -20.21% |
| 2022 Q1 | 18.51 Billion IDR | -8.72% |
| 2022 Q4 | 16.18 Billion IDR | -7.5% |
| 2022 Q2 | 16.45 Billion IDR | -11.12% |
| 2022 Q3 | 17.49 Billion IDR | 6.33% |
| 2021 Q2 | 22.65 Billion IDR | -5.95% |
| 2021 FY | 20.28 Billion IDR | -7.89% |
| 2021 Q4 | 20.28 Billion IDR | -16.98% |
| 2021 Q1 | 24.09 Billion IDR | 9.42% |
| 2021 Q3 | 24.43 Billion IDR | 7.82% |
| 2020 Q3 | 26.43 Billion IDR | 465.55% |
| 2020 Q1 | 10.76 Billion IDR | 767.88% |
| 2020 Q2 | 4.67 Billion IDR | -56.6% |
| 2020 FY | 22.02 Billion IDR | 1674.58% |
| 2020 Q4 | 22.02 Billion IDR | -16.69% |
| 2019 Q2 | 18.11 Billion IDR | -7.82% |
| 2019 Q3 | - IDR | -100.0% |
| 2019 Q4 | 1.24 Billion IDR | 0.0% |
| 2019 Q1 | 19.65 Billion IDR | 585.78% |
| 2019 FY | 1.24 Billion IDR | -56.7% |
| 2018 Q2 | 1.67 Billion IDR | -1.42% |
| 2018 FY | 2.86 Billion IDR | -12.65% |
| 2018 Q4 | 2.86 Billion IDR | 73.04% |
| 2018 Q3 | 1.65 Billion IDR | -0.83% |
| 2018 Q1 | 1.69 Billion IDR | -48.37% |
| 2017 Q2 | 30 Billion IDR | 0.0% |
| 2017 Q1 | - IDR | 0.0% |
| 2017 FY | 3.28 Billion IDR | 0.0% |
| 2017 Q4 | 3.28 Billion IDR | -83.59% |
| 2017 Q3 | 20 Billion IDR | -33.33% |
| 2016 Q3 | - IDR | 0.0% |
| 2016 FY | - IDR | 0.0% |
| 2016 Q4 | - IDR | 0.0% |
| 2016 Q2 | - IDR | 0.0% |
| 2016 Q1 | - IDR | 0.0% |
| 2015 FY | - IDR | 0.0% |
| 2015 Q1 | - IDR | 0.0% |
| 2015 Q2 | - IDR | 0.0% |
| 2015 Q3 | - IDR | 0.0% |
| 2015 Q4 | - IDR | 0.0% |
| 2014 Q3 | - IDR | 0.0% |
| 2014 FY | - IDR | 0.0% |
| 2014 Q2 | - IDR | 0.0% |
| 2014 Q4 | - IDR | 0.0% |
| 2014 Q1 | - IDR | 0.0% |
| 2013 FY | - IDR | 0.0% |
| 2013 Q2 | - IDR | 0.0% |
| 2013 Q1 | - IDR | 0.0% |
| 2013 Q4 | - IDR | 0.0% |
| 2013 Q3 | - IDR | 0.0% |
| 2012 Q1 | - IDR | 0.0% |
| 2012 FY | - IDR | 0.0% |
| 2012 Q4 | - IDR | 0.0% |
| 2012 Q3 | - IDR | 0.0% |
| 2012 Q2 | - IDR | 0.0% |
| 2011 Q4 | - IDR | 0.0% |
| 2011 Q1 | - IDR | 0.0% |
| 2011 FY | - IDR | 0.0% |
| 2010 Q4 | - IDR | 0.0% |
| 2010 FY | - IDR | 0.0% |
| 2010 Q1 | - IDR | 0.0% |
| 2010 Q3 | - IDR | 0.0% |
| 2009 Q4 | - IDR | 0.0% |
| 2009 FY | - IDR | 0.0% |
| 2008 FY | - IDR | 0.0% |
| 2007 FY | - IDR | 0.0% |
| 2006 FY | - IDR | 0.0% |
| 2005 FY | - IDR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| PT Darya-Varia Laboratoria Tbk | 1.47 Billion IDR | -1129.999% |
| PT Phapros, Tbk | 802.57 Billion IDR | 97.741% |
| PT Pyridam Farma Tbk | 986.99 Billion IDR | 98.163% |
| PT Industri Jamu dan Farmasi Sido Muncul Tbk | 9.39 Billion IDR | -93.086% |
| PT Tempo Scan Pacific Tbk | 1116.39 Billion IDR | 98.376% |